Search

1240993
1240861
1230819
1195994
393884
Primary Analysis results from M72/AS01E vaccine trial
In a a multicenter, double-blind, randomised, placebo-controlled trial conducted in three African countries in which tuberculosis is endemic (Kenya, South Africa, and Zambia), the M72/AS01E TB vaccine provided 54.0% protection for M. tuberculosis–...
Social Reponsiveness
Established in 2001, the South African Tuberculosis Vaccine Initiative (SATVI) was presented with the University of Cape Town’s (UCT) 2018 Social Responsiveness Award at the Faculty of Health Sciences graduation ceremony on Saturday, 13 April 2019
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Friday, 23 August 2019
6 March 2019 Latest Research: A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates

SATVI researchers Miguel Rodo, Professor Tom Scriba, Drs. Virginie Rozot, Elisa Nemes and Profesor Mark Hatherill have published a article titled: "A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates" appearing in the PLoS Pathogens journal.

Publication Date:
Tue, 05 Mar 2019 - 20:15
4 March 2019: 2018 Annual Report Now Available

The South African Tuberculosis Vaccine Initiative 2018 Annual Report is now available. 

Publication Date:
Tue, 05 Mar 2019 - 18:45
19 January 2019 Research Published: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria

SATVI Authors Professors Mark Hatherill, Tom Scriba, Dr Munyaradzi Musvosvi, Humphrey Mulenga, Ashley Veldsman have co-authored a research paper titled "Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria" appearing in the PLos One Journal.

Publication Date:
Mon, 04 Feb 2019 - 15:00
17 January 2019 Research Published: Batf2 differentially regulates tissue immunopathology in Type 1 and 2 diseases

Professor Tom Scriba and Dr Adam Penn-Nicholson have co-authored a research publication titled: "Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases" appearing in the Mucosal Immunology Journal.

Publication Date:
Mon, 04 Feb 2019 - 14:30

Pages